Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai Pioneer HoldingHKSE:01345 -1.75%73 Operating Margin % is 11.55% as of Dec. 2025, which is 9% below its 10-year median of 12.73. GuruFocus rates HKSE:01345 with a GF Score™ of 73/100 and a GF Value™ of HK$1.80 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 663 Healthcare Providers & Services companies, Shanghai Pioneer Holding ranks better than 73% on this metric.
Shanghai Pioneer Holding Ltd operating margin is expanding. Margin expansion is usually a good sign.
The historical rank and industry rank for Shanghai Pioneer Holding's Operating Margin % or its related term are showing as below:
HKSE:01345'
s Operating Margin % Range Over the Past 10 Years
Min: 8.04 Med: 12.73 Max: 15.36
Current: 11.3
HKSE:01345's Operating Margin % is ranked better than 73% of 663
companies
in the Healthcare Providers & Services industry
Industry Median: 4.85
vs HKSE:01345: 11.30
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Shanghai Pioneer Holding Operating Margin % Related Terms
Shanghai Pioneer Holding Operating Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Shanghai Pioneer Holding's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Pioneer Holding Operating Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Shanghai Pioneer Holding's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Shanghai Pioneer Holding's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Shanghai Pioneer Holding's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Pioneer Holding (HKSE:01345) has a Operating Margin % of 11.55% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Shanghai Pioneer Holding and its competitors. This is near median its historical median of 12.73. Over the past decade, Shanghai Pioneer Holding's Operating Margin % has ranged from 8.04 to 15.36. According to the industry distribution chart, Shanghai Pioneer Holding ranks #179 out of 663 companies in the Healthcare Providers & Services industry, placing it in the top 27%.
Is Shanghai Pioneer Holding's Operating Margin % too high?
Shanghai Pioneer Holding's current Operating Margin % of 11.55% is near median its 10-year median of 12.73. Over the past 10 years, this metric has ranged from a low of 8.04 to a high of 15.36. The Healthcare Providers & Services industry median Operating Margin % is 4.85. Shanghai Pioneer Holding's value of 11.55% is 138.1% above this industry median. Based on the distribution chart, Shanghai Pioneer Holding ranks #179 out of 663 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Shanghai Pioneer Holding has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Pioneer Holding's Operating Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Shanghai Pioneer Holding ranks #179 out of 663 companies for Operating Margin %. This puts Shanghai Pioneer Holding in the upper half of its industry. The industry median Operating Margin % is 4.85. Shanghai Pioneer Holding's value of 11.55% is 138.1% above this benchmark. Historically, Shanghai Pioneer Holding's own Operating Margin % has ranged from 8.04 to 15.36 over the past decade. While the company's 10-year median is 12.73 vs. the industry median of 4.85, Shanghai Pioneer Holding has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Healthcare Providers & Services company?
The median Operating Margin % among Healthcare Providers & Services companies is 4.85, based on 663 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Pioneer Holding's current Operating Margin % of 11.55% is 138.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Shanghai Pioneer Holding and its competitors. For the Healthcare Providers & Services industry, the median Operating Margin % is 4.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Pioneer Holding's current Operating Margin % is 11.55%, which is near median its own 10-year median of 12.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Pioneer Holding stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Pioneer Holding (HKSE:01345) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$1.80, compared to a current price of HK$2.25 — trading 25% above its estimated fair value. The current Operating Margin % is 11.55%, which is near median its 10-year median of 12.73 and 138.1% above the Healthcare Providers & Services industry median of 4.85. Shanghai Pioneer Holding's overall GF Score™ is 73/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Shanghai Pioneer Holding (HKSE:01345), the current Operating Margin % is 11.55% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Pioneer Holding (HKSE:01345) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Pioneer Holding stock appears to be overvalued.
The current stock price of HK$2.25 is trading 25% above its estimated GF Value™ of HK$1.80.
GuruFocus considers Shanghai Pioneer Holding to be Modestly Overvalued.
Key valuation signals for HKSE:01345:
Operating Margin %: 11.55% (near median its 10-year median of 12.73)
GF Value™: HK$1.80 vs. price of HK$2.25 (25% above fair value)
Industry Position: 138.1% above the Healthcare Providers & Services median (#179 of 663)
No single metric tells the full story. See the HKSE:01345 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Pioneer Holding Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the marketing, promotion, sales, and channel management service for imported pharmaceutical products and medical devices in China. The company has a portfolio of pharmaceutical products, covering ophthalmology, pain management, cardiovascular, gastroenterology, immunology, gynecology, and other therapeutic areas, and medical devices covering several medical specialties, including ophthalmology, odontology, cardiology and wound care products. The majority of its revenue derives from the Sales of medical equipment and supplies. The group operates mainly in the People's Republic of China.
73GF Score
Get the complete analysis for HKSE:01345
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01345 has been successfully added to your 
